Medicinal chemistry FTE
A multidisciplinary approach here involves the application of a systematic design, make, test, analyze (DMTA) cycle to ensure fast and efficient progress. Medicinal Chemistry FTE is an iterative process whereby new compounds are designed, synthesized and tested in various assays. The results are then analyzed and fed into the next round of designs. The more iterations with good quality chemistry and focused assay design, the faster the progress. Critically important to the success of this entire process is the ability to fully consider the data, to understand its implications and examine how it informs the next course of action. Here, multi-disciplinary interactions and dialogue stand out by adding real value and accelerating progress towards the development.
Developing an optimal drug profile requires expertise. ChemDiv supports you in every step of the process to improve specific parameters of molecules and progress series from a hit to a lead and to a successful clinical candidate.
-
Excellent track record for delivering multiple leads and clinical candidates for our customers and partners
-
Top scientists with background in medicinal, computational and synthetic chemistry as well as in vitro and in vivo biology assist in progressing molecules from design to market launch
-
Well-earned international reputation in unique scaffold design and library synthesis
-
A combination of SAR efforts through ADMET evaluation in scaffold design and early PK PD/Tox allows us to guide design of high quality lead candidates and back-ups
-
Seamless integration of all products and services upon customer request
-
Flexibility towards specific requirements of customer medicinal chemistry programs
-
Transparent communication, forward R&D planning, regular reporting and meetings
-
Stellar experience, expertise and infrastructure